Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Intrinsic Value
Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. [ Read More ]
The intrinsic value of one
Chongqing Zhifei Biological Products Co Ltd
stock under the Base Case scenario is
77.53
CNY.
Compared to the current market price of 34.3 CNY,
Chongqing Zhifei Biological Products Co Ltd
is
Undervalued by 56%.
Chongqing Zhifei Biological Products Co Ltd's market capitalization is 82.3B CNY.
Chongqing Zhifei Biological Products Co Ltd stock price is 34.3 CNY.
Chongqing Zhifei Biological Products Co Ltd stock price (34.3 CNY) is 56% less than its Intrinsic Value (77.53 CNY).
Chongqing Zhifei Biological Products Co Ltd stock price (34.3 CNY) is 41% less than its DCF Value (58.08 CNY). Open DCF Valuation
Chongqing Zhifei Biological Products Co Ltd stock price (34.3 CNY) is 65% less than its Relative Value (96.98 CNY). Open Relative Valuation
Chongqing Zhifei Biological Products Co Ltd has upside potential of 99% compared to the average analyst price target.
Open Wall St Estimates
Chongqing Zhifei Biological Products Co Ltd has positive Net Debt. This means that the company has more debt (4B CNY) than cash and short-term investments (3B CNY).
Chongqing Zhifei Biological Products Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 36% to 30%.
Chongqing Zhifei Biological Products Co Ltd's Revenue has grown by an exceptional 36% over the past 12 months.
Chongqing Zhifei Biological Products Co Ltd has positive Net Income for the last twelve months.
Chongqing Zhifei Biological Products Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 30%.
Chongqing Zhifei Biological Products Co Ltd's Revenue is forecast to grow at a rate of 23% per year over the next 3 years.
Chongqing Zhifei Biological Products Co Ltd's ROE (Return on Equity) has significantly decreased in the last 3 years from 48% to 32%.
Chongqing Zhifei Biological Products Co Ltd's ROE (Return on Equity) for the past 12 months is very high and is equal to 32%.
Chongqing Zhifei Biological Products Co Ltd has positive Operating Income for the last twelve months.
Chongqing Zhifei Biological Products Co Ltd has positive Free Cash Flow for the last twelve months.
Chongqing Zhifei Biological Products Co Ltd has positive Gross Profit for the last twelve months.
Chongqing Zhifei Biological Products Co Ltd's short-term assets (42B CNY) exceed its short-term liabilties (19B CNY).
Chongqing Zhifei Biological Products Co Ltd's long-term assets (49B CNY) exceed its long-term liabilties (19B CNY).
Chongqing Zhifei Biological Products Co Ltd's Revenue has been growing by an exceptional 53% per year for the last 3 years.
Chongqing Zhifei Biological Products Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.14.
Chongqing Zhifei Biological Products Co Ltd has very high three-year average ROIC (Return on Invested Capital): 47%. The company is very efficient at using invested capital to generate operating income.
Chongqing Zhifei Biological Products Co Ltd has very high three-year average ROE (Return on Equity): 52%. The company is very efficient at transforming stockholders' equity into net income.
Chongqing Zhifei Biological Products Co Ltd's Altman Z-Score is very high and is equal to 6.68.
Valuation Backtest
Chongqing Zhifei Biological Products Co Ltd
Run backtest to discover the historical profit from buying and selling
Chongqing Zhifei Biological Products Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Chongqing Zhifei Biological Products Co Ltd
Balance Sheet Decomposition
Chongqing Zhifei Biological Products Co Ltd
| Current Assets | 42.1B |
| Cash & Short-Term Investments | 2.9B |
| Receivables | 28.6B |
| Other Current Assets | 10.5B |
| Non-Current Assets | 7.2B |
| Long-Term Investments | 294.1m |
| PP&E | 5B |
| Intangibles | 1.2B |
| Other Non-Current Assets | 736.8m |
| Current Liabilities | 18.6B |
| Accounts Payable | 13.2B |
| Accrued Liabilities | 58.8m |
| Short-Term Debt | 4B |
| Other Current Liabilities | 1.5B |
| Non-Current Liabilities | 666.8m |
| Long-Term Debt | 366.6m |
| Other Non-Current Liabilities | 300.2m |
Earnings Waterfall
Chongqing Zhifei Biological Products Co Ltd
|
Revenue
|
49.7B
CNY
|
|
Cost of Revenue
|
-35.2B
CNY
|
|
Gross Profit
|
14.5B
CNY
|
|
Operating Expenses
|
-4.6B
CNY
|
|
Operating Income
|
9.9B
CNY
|
|
Other Expenses
|
-1.4B
CNY
|
|
Net Income
|
8.5B
CNY
|
Free Cash Flow Analysis
Chongqing Zhifei Biological Products Co Ltd
Profitability Score
Profitability Due Diligence
Chongqing Zhifei Biological Products Co Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
Score
Chongqing Zhifei Biological Products Co Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Chongqing Zhifei Biological Products Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Score
Chongqing Zhifei Biological Products Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Chongqing Zhifei Biological Products Co Ltd
According to Wall Street analysts, the average 1-year price target for
Chongqing Zhifei Biological Products Co Ltd
is 68.37 CNY
with a low forecast of 54.72 CNY and a high forecast of 82.95 CNY.
Shareholder Return
Price
Chongqing Zhifei Biological Products Co Ltd
| Average Annual Return | 39.76% |
| Standard Deviation of Annual Returns | 98.09% |
| Max Drawdown | -78% |
| Market Capitalization | 82.4B CNY |
| Shares Outstanding | 2 393 789 952 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Chongqing Zhifei Biological Products Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. The company is headquartered in Chongqing, Chongqing and currently employs 4,800 full-time employees. The company went IPO on 2010-09-28. The firm's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevision and treatment of tuberculosis, viral vaccines for the prevention of rabies virus, influenza virus and other virus, general drugs and other biological products, among others. The firm is also involved in the agency sale of vaccines. The firm distributes its products in domestic market and to overseas markets, with Central China as its main market.
Contact
IPO
Employees
Officers
The intrinsic value of one
Chongqing Zhifei Biological Products Co Ltd
stock under the Base Case scenario is
77.53
CNY.
Compared to the current market price of 34.3 CNY,
Chongqing Zhifei Biological Products Co Ltd
is
Undervalued by 56%.
You don't have any saved screeners yet
